Tag: COVID-19
-
COVID-19 Surge: India Sees 752 New Covid Cases, 4 Deaths In 24 Hours
With the holiday season and colder winter months looming, COVID-19 cases have increased in India. People in India are getting infected with COVID new subvariant JN.1. In the last 24 hours, India witnessed 752 new COVID cases and four deaths. India recorded its highest single day rise on 23 December. According to the Union Health ... -
The Vaccine War: A Tribute To Indian Scientists, Now On OTT
“The Vaccine War” film has created a significant buzz in the media and among the public since its release in theaters. This film is not just a movie; it’s a tribute to the unconquerable spirit of Indian scientists and a revelation of the challenges they faced during the COVID-19 pandemic. OTT Launch of ‘The Vaccine ... -
Reliance Jio To Launch Affordable JioBook Laptop with 4G Connectivity
Reliance Jio, led by Mukesh Ambani, is set to launch a new 4G-enabled laptop called JioBook. The laptop is expected to be affordable and targeted towards students. It was previously showcased at the India Mobile Congress and listed on the Government e-Marketplace for government officials. The new JioBook will be available to the general public ... -
COVID: Indians Have Stronger Immune System, 95% Indians Are Vaccinated
Experts believe that India is safer, compared to other nations. 95% Indians are already vaccinated & they’ve stronger immunity. However they must be cautious! As COVID-19 continues to spread its venom throughout China, there are now rumors of India being locked down. A few cases of a COVID subvariant known as “BF.7” were reported in ... -
Agendas for Quad Summit between Narendra Modi and Joe Biden
The subsequent changes in the social, geopolitical, and economic balance in the Indo-Pacific region in the last year have brought the recent Prime Minister Narendra Modi meeting with the US President Joe Biden. This first in-person meet of the Quad Summit will be reviewing the vaccine initiatives and the spiking global issues of cyber security, ... -
Tata Jumps The Bandwagon To Develop Vaccine With Moderna In India
Tata is planning to tie up with the American pharmaceutical company Moderna to bring in the Covid-19 vaccine. Moderna has developed one more candidate of the vaccine that guarantees comparatively lower efficacy levels in comparison to the other vaccine candidates. For this, Indian giant Tata will be putting its healthcare unit Tata Medical and Diagnostics ... -
Indian Extended Hand Over Vaccines To Neighbours Hurts Chinese Ego
India has helped push China back as its generous gesture of donating the indigenously done Astra Zeneca Covid-19 vaccine is getting praises from its South Asian patrons. India has sent off a supply manufactured by the Serum Institute of India. Supplies have started to be sent to the Maldives, Bhutan, Bangladesh, and Nepal. Myanmar and ... -
Why Reduction Of Infectious Cases Is Not Good News For Indian Covid-19 Vaccine Candidates
Reduction Of Infectious Cases: The efficacy of the Covid-19 vaccine could be affected if the Covid-19 virus infections come down, confirms official reports. The researchers are stating that it would be difficult for them to test the vaccine in its third phase. This is primarily for the other vaccine candidates being developed and could delay ... -
India Moves Ahead Into Self Reliance With Domestic Coronavirus Vaccine
Domestic Coronavirus Vaccine: Keeping his promise of making India self-reliant, PM Narendra Modi expressed his joy in announcing two homemade Corona virus vaccines would be made available to public soon. Speaking on the virtual inauguration of the 16th Pravasi Bharatiya Divas convention, Modi addressed the nation and expressed his joy over things that happened in ... -
Indian Government Restricts Poonawalla To Export Indian Vaccine
Indian Vaccine Export: Black marketing of the Covid-19 vaccine might not trouble India after all. Recent reports confirm that the Indian vaccine maker Serum Institute CEO Adar Poonawalla has been strictly told that the Indian government approved Astra Zeneca Oxford vaccine will not be available into the private market for several months, after it is released ...